Molecular-targeted nanotherapies in cancer: Enabling treatment specificity
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular-targeted nanotherapies in cancer: Enabling treatment specificity
Authors
Keywords
-
Journal
Molecular Oncology
Volume 5, Issue 6, Pages 492-503
Publisher
Wiley
Online
2011-11-01
DOI
10.1016/j.molonc.2011.10.005
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Growth-Inhibitory and Antiangiogenic Activity of the MEK Inhibitor PD0325901 in Malignant Melanoma with or without BRAF Mutations
- (2015) Ludovica Ciuffreda et al. NEOPLASIA
- Long-term toxic effects of adjuvant chemotherapy in breast cancer
- (2011) H. A. Azim et al. ANNALS OF ONCOLOGY
- Early dissemination of bevacizumab for advanced colorectal cancer: a prospective cohort study
- (2011) S Yousuf Zafar et al. BMC CANCER
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Efficacy of taxanes as adjuvant treatment of breast cancer: a review and meta-analysis of randomised clinical trials
- (2011) Jordi Ginés et al. Clinical & Translational Oncology
- Zoledronic acid for adjuvant use in patients with breast cancer
- (2011) Sigrun Ressler et al. Expert Review of Anticancer Therapy
- Synthesis and evaluation of poly(styrene-co-maleic acid) micellar nanocarriers for the delivery of tanespimycin
- (2011) Nate Larson et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Targeting HSP 90 Induces Apoptosis and Inhibits Critical Survival and Proliferation Pathways in Multiple Myeloma
- (2011) T. Khong et al. MOLECULAR CANCER THERAPEUTICS
- Nanomedicine(s) under the Microscope
- (2011) Ruth Duncan et al. MOLECULAR PHARMACEUTICS
- Nanotechnologies to use bisphosphonates as potent anticancer agents: the effects of zoledronic acid encapsulated into liposomes
- (2011) Monica Marra et al. Nanomedicine-Nanotechnology Biology and Medicine
- Peaking beneath the surface of recent bevacizumab trials
- (2011) Ana M. Gonzalez-Angulo et al. Nature Reviews Clinical Oncology
- Cationic Liposomal Co-delivery of Small Interfering RNA and a MEK Inhibitor for Enhanced Anticancer Efficacy
- (2011) Seung Hee Kang et al. PHARMACEUTICAL RESEARCH
- Improving Drug Potency and Efficacy by Nanocarrier-Mediated Subcellular Targeting
- (2011) M. Murakami et al. Science Translational Medicine
- Targeted near-IR QDs-loaded micelles for cancer therapy and imaging
- (2010) Md. Nurunnabi et al. BIOMATERIALS
- A multicentre Phase II study of non-pegylated liposomal doxorubicin in combination with trastuzumab and docetaxel as first-line therapy in metastatic breast cancer
- (2010) M. Venturini et al. BREAST
- The antitumor activity of NK012, an SN-38-incorporating micelle, in combination with bevacizumab against lung cancer xenografts
- (2010) Hirotsugu Kenmotsu et al. CANCER
- Sustained Small Interfering RNA Delivery by Mesoporous Silicon Particles
- (2010) Takemi Tanaka et al. CANCER RESEARCH
- -Lapachone Micellar Nanotherapeutics for Non-Small Cell Lung Cancer Therapy
- (2010) E. Blanco et al. CANCER RESEARCH
- Tailored Porous Silicon Microparticles: Fabrication and Properties
- (2010) Ciro Chiappini et al. CHEMPHYSCHEM
- Emerging Targeted Therapies for Breast Cancer
- (2010) Ricardo H. Alvarez et al. JOURNAL OF CLINICAL ONCOLOGY
- Promise and Challenge of RNA Interference–Based Therapy for Cancer
- (2010) Fabio Petrocca et al. JOURNAL OF CLINICAL ONCOLOGY
- How Do You Tell Whether a Breast Cancer is HER2 Positive? Ongoing Studies Keep Debate in High Gear
- (2010) C. Schmidt JNCI-Journal of the National Cancer Institute
- Conjugation of bevacizumab to cationic liposomes enhances their tumor-targeting potential
- (2010) Geoffrey M Kuesters et al. Nanomedicine
- Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
- (2010) Mark E. Davis et al. NATURE
- Vectoring siRNA therapeutics into the clinic
- (2010) Mauro Ferrari Nature Reviews Clinical Oncology
- HER2 targeting as a two-sided strategy for breast cancer diagnosis and treatment: Outlook and recent implications in nanomedical approaches
- (2010) Miriam Colombo et al. PHARMACOLOGICAL RESEARCH
- Frontiers in cancer nanomedicine: directing mass transport through biological barriers
- (2010) Mauro Ferrari TRENDS IN BIOTECHNOLOGY
- The association of silicon microparticles with endothelial cells in drug delivery to the vasculature
- (2009) Rita E. Serda et al. BIOMATERIALS
- Combination chemotherapy of doxorubicin and paclitaxel for hepatocellular carcinoma in vitro and in vivo
- (2009) Cheng Jin et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Size and shape effects in the biodistribution of intravascularly injected particles
- (2009) P. Decuzzi et al. JOURNAL OF CONTROLLED RELEASE
- Development of a highly stable and targetable nanoliposomal formulation of topotecan
- (2009) Daryl C. Drummond et al. JOURNAL OF CONTROLLED RELEASE
- The First Targeted Delivery of siRNA in Humans via a Self-Assembling, Cyclodextrin Polymer-Based Nanoparticle: From Concept to Clinic
- (2009) Mark E. Davis MOLECULAR PHARMACEUTICS
- Src kinases as therapeutic targets for cancer
- (2009) Lori C. Kim et al. Nature Reviews Clinical Oncology
- Bioconjugated quantum dots for in vivo molecular and cellular imaging☆
- (2008) A SMITH et al. ADVANCED DRUG DELIVERY REVIEWS
- Targeting Angiogenesis Driven by Vascular Endothelial Growth Factors Using Antibody-Based Therapies
- (2008) Axel Grothey et al. CANCER JOURNAL
- Cytotoxic effects of a novel pyrazolopyrimidine derivative entrapped in liposomes in anaplastic thyroid cancer cells in vitro and in xenograft tumors in vivo
- (2008) M Celano et al. ENDOCRINE-RELATED CANCER
- Multifunctional Micellar Nanomedicine for Cancer Therapy
- (2008) Elvin Blanco et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancer
- (2008) Sun Hwa Kim et al. JOURNAL OF CONTROLLED RELEASE
- The prince and the pauper. A tale of anticancer targeted agents
- (2008) Alfonso Dueñas-González et al. Molecular Cancer
- Beyond drug delivery
- (2008) Mauro Ferrari Nature Nanotechnology
- Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications
- (2008) Ennio Tasciotti et al. Nature Nanotechnology
- Intravascular Delivery of Particulate Systems: Does Geometry Really Matter?
- (2008) Paolo Decuzzi et al. PHARMACEUTICAL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation